Thermo Fisher Scientific Expands Steriles Manufacturing and Research Capabilities in Asia-Pacific Region
Pharmaceutical developers are under pressure to rapidly advance products to the next clinical milestone. In early development, decisions are made regarding how much should be invested in API process development, characterization, and other parts of the workflow. Not making the right decisions can lead to challenges with drug-product formulation and even clinical data.
Join pharma services expert, Dr. Peter Poechlauer, as he examines the process of identifying and solving scale-up challenges in the synthesis and formulation of small-molecule APIs.